WCAMG
MGNX icon

Woodard & Company Asset Management Group’s MacroGenics MGNX Stock Holding History

Woodard & Company Asset Management Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-60
Closed – – 149
2018
Q3 		$0 Hold
60
– – ﹤0.01% 261
2018
Q2 		$1.24K Hold
60
– – ﹤0.01% 198
2018
Q1 		$2K Hold
60
– – ﹤0.01% 195
2017
Q4 		$0 Buy
+60
New +$1.12K ﹤0.01% 229

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Woodard & Company Asset Management Group's MGNX Position: Q4 2018 in Review

Woodard & Company Asset Management Group sold out of MacroGenics (MGNX) in Q4 2018, closing a stake of 60 shares.

Woodard & Company Asset Management Group first reported a position in MGNX in Q4 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2018. 133 funds tracked by Wall St. Rank hold MGNX as of Q4 2018.

  • Woodard & Company Asset Management Group reported no remaining MacroGenics position as of Q4 2018 after selling out during the quarter.
  • Woodard & Company Asset Management Group sold 60 MacroGenics shares in Q4 2018.
  • Woodard & Company Asset Management Group first reported a position in MacroGenics in Q4 2017 and held it in 4 quarters.
  • Woodard & Company Asset Management Group's MacroGenics position peaked at $2K in Q1 2018.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q4 2018.

Based on Woodard & Company Asset Management Group's 13F filing for Q4 2018, filed 1 Feb 2019.